Globus Medical price target raised to $93 from $85 at Barclays

Barclays raised the firm’s price target on Globus Medical to $93 from $85 and keeps an Overweight rating on the shares. The company reported “another strong beat” with 12.5% organic sales growth against a solid 11.0% prior year comp, the analyst tells investors in a research note.